Mediamedic/LinkedIn
Oct 4, 2025, 10:05
ISEH 2025 China–Japan Dialogue With Professors Jianxiang Wang and Naoki Hosen
Mediamedic shared a post on LinkedIn:
“ISEH 2025 China–Japan Dialogue | Professors Jianxiang Wang & Naoki Hosen: CAR-T Therapy for Leukemia and Global Collaboration
At the 54th ISEH Annual Scientific Meeting in Kumamoto, Japan, Professor Jianxiang Wang (Institute of Hematology & Blood Diseases Hospital, CAMS) and Professor Naoki Hosen (Osaka University) engaged in a deep dialogue on the future of CAR-T therapy for leukemia.
Their conversation explored basic mechanisms, clinical applications, efficacy optimization, and future directions, highlighting the importance of international collaboration to expand innovation and patient access worldwide.”
Stay updated with Hemostasis Today.
-
Aug 26, 2026, 18:38Maia Meier: Muhiba’s Story of Courage, Resilience and Hope With Type 3 VWD
-
Aug 26, 2026, 18:27Isabella Presch: Not Every Genome-Editing Program Needs to Start From Zero
-
Aug 26, 2026, 18:24New Educational Content for the Bleeding Disorders Community – EAHAD
-
Aug 26, 2026, 18:14N. Mariana S. Vasquez: From Skin and Gut to Celiac Disease
-
Aug 26, 2026, 18:13Francesca Granata: What Happens When Patients Become Researchers and Researchers Become Advocates?
-
Aug 26, 2026, 18:11Maxima Mendez: Statins Are No Longer the Whole Story
-
Aug 26, 2026, 18:06Ashkan Shoamanesh: ANNEXa-I Analyses Inform Individualized Treatment in Intracranial Hemorrhage
-
Aug 26, 2026, 18:01Sam Tsimikas: Lp(a) and Oxidized Phospholipids Reveal a New Link Between Hypercoagulability and Stronger Clot Formation
-
Aug 26, 2026, 17:52Kamlesh Darji: A Practical Guide to Interpreting Coagulation Tests